CROI 2024 Report Back: Treatment Updates

preview_player
Показать описание
Dr. Jehan Budak summarizes key study results from the CROI 2024 conference that focus on antiretroviral treatment, especially long-acting injectable cabotegravir/rilpivirine and lenacapavir.
Рекомендации по теме
welcome to shbcf.ru